Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Advik Laboratories Ltd.

  • NSE: ADVIKLA

  • BSE: 531686

  • Q
  • V
  • T
0.00/100

Quality Score

Not Eligible
0.00/100

Valuation Score

Expensive Valuation
22.51/100

Technical Score

Technically Bearish
Broker Average Rating

0.00

Broker Average Rating

MFI

97.39

MFI strongly Overbought

50Day SMA Rs

0.41 Rs

Price below SMA-50

Quality score

0.00

Not Eligible

30Day SMA Rs

0.35 Rs

Price above SMA 0.35

Broker Covering stock

0.00

None Broker Covering stock

Broker 6M Target upgrade

0.00

None Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

None Broker 6M Target downgrade

Momentum score

22.51

Technically Bearish

Broker Reports in 1Yr

0.00

None Broker Reports in 1Yr

TTM PE Ratio

-0.60

Negative PE Trailing 12M

Broker 6M Reco upgrade

0.00

None Broker 6M Reco upgrade

RSI

43.10

RSI is mid-range

Net Profit Qtr Cr

-0.26 Cr

Negative Net Profit Qtr Cr

AVG Broker Target

0.00 %

No targets last year

MACD

-0.02

MACD below Center

Valuation score

0.00

Expensive Valuation

MACD Signal Line

-0.03

MACD below Center

FII holding holding %

0.00 %

FII holding holding

Promoter holding holding %

35.89 %

No change in Promoter holding

MF holding holding %

0.00 %

MF holding holding

Broker 6M Reco downgrade

0.00

None Broker 6M Reco downgrade

100Day SMA Rs

0.79 Rs

Price below SMA-100

Institutions holding holding %

0.00 %

Institutions holding holding

AVG Broker Target

0.00 Rs

No targets last year

200Day SMA Rs

1.62 Rs

Price below SMA-200

Company is not Listed On NSE

    • 2020-09-12T12:51:48+00:00

    ADVIK LABORATORIES LTD. - 531686 - Intimation For Extension Of Annual General Meeting Of The Company For The Financial Year Ended March 31, 2020

    Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors in its meeting held on 09th September, 2020 has considered the Order No ROC/Delhi/AGM Ext./2020/11538 dated 08.09.2020 issued by Hon'ble ROC - NCT of Delhi & Haryana w.r.t. extension of the due date of the Annual General Meeting for the financial year ended on 31.03.2020 up to 3 Months from the due date of the AGM and the Board has decided to avail the said exemption granted by Hon'ble ROC- NCT of Delhi & Haryana. The intimation for such extension has already been given to the Exchange vide our letter dated 09 th September, 2020 w.r.t. Outcome of the Board Meeting. Hence, as per the above order issued by the Hon'ble ROC - NCT of Delhi & Haryana, the Annual General Meeting of the Company for the financial year ended March 31, 2020 shall be held within such extended time, i.e. on or before December 31, 2020 and the date of AGM shall be intimated to the Exchange in due course.

    Read More
    • 2020-09-10T07:38:26+00:00

    ADVIK LABORATORIES LTD. - 531686 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Submission of Newspaper Publication published on 10th September, 2020 w.r.t Un-Audited Financial Results for the quarter ended 30th June, 2020

    Read More
    • 2020-09-09T12:33:57+00:00

    ADVIK LABORATORIES LTD. - 531686 - Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter Ended 30Th June,2O2O As Required U/R 33 Of The SEBI (LODR) Regulations, 2015

    Outcome of the Board Meeting and Submission of Un-audited Financial Resultsfor the quarter ended 30th June,2O2O as required u/r 33 of the SEBI (LODR) Regulations, 2015

    Read More
    • 2020-09-09T12:29:26+00:00

    ADVIK LABORATORIES LTD. - 531686 - Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter Ended 30Th June,2O2O As Required U/R 33 Of The SEBI (LODR) Regulations, 2015.

    Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Wednesday, 09th September,2020 at the corporate office of the company inter-alia, transacted the following businesses: 1. Considered and Approved the Standalone Un-audited Financial Results for the quarter ended 30th June, 2020. 2. Considered and Approved the Limited Review Report for the quarter ended 30th June, 2020. Further, it is hereby informed that the Hon''ble ROC - NCT of Delhi & Haryana vide its Order No ROC/Delhi/AGM Ext./2020/11538 dated 08.09.2020, has allowed the general extension of time for a period of three months to hold the AGM for the financial year ended on 31.03.2020 upto 31.12.2020. The Board has also considered the aforesaid Order and has decided to avail the exemption granted by Hon''ble ROC- NCT of Delhi & Haryana.

    Read More
    • 2020-09-03T09:07:21+00:00

    ADVIK LABORATORIES LTD. - 531686 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 33 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find enclosed herewith a copy of newspaper publication w.r.t Notice of Board Meeting for considering the Un-Audited Financial Results for the quarter ended 30th June, 2020, published on 3rd September, 2020 in 'Financial Express', English and 'Jansatta', Hindi Newspaper, All India Edition.

    Read More
    • 2020-09-02T07:33:14+00:00

    ADVIK LABORATORIES LTD. - 531686 - Board Meeting Intimation for Notice Of Board Meeting To Consider Un-Audited Financial Results Of The Company For The Quarter Ended 30Th June, 2020

    ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/09/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Wednesday, 9th September, 2020 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001 to inter-alia, consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2020 and to carry on any other business with the permission of the Board.

    Read More
    • 2020-08-14T09:52:49+00:00

    ADVIK LABORATORIES LTD. - 531686 - Disclosure Of Related Party Transaction For The Half Year Ended 31St March , 2O2O Pursuant To Regulation 23(9) Of The Sebt (LODR), Regulation,2O15

    As per the requirement of Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure under "Related Party Transaction" for the half year ended 31st March, 2020, as per the Indian Accounting Standard (IND AS) 24.

    Read More
    • 2020-08-14T09:51:28+00:00

    ADVIK LABORATORIES LTD. - 531686 - Disclosure Of Related Party Transaction For The Half Year Ended 31St March , 2O2O Pursuant To Regulation 23(9) Of The Sebt (LODR), Regulation,2O15

    As per the requirement of Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure under "Related Party Transaction" for the half year ended 31st March, 2020, as per the Indian Accounting Standard (IND AS) 24.

    Read More
    • 2020-07-31T08:54:55+00:00

    ADVIK LABORATORIES LTD. - 531686 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015, please find enclosed herewith a copy of newspaper publication w.r.t Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2020, published on 31st July, 2020, in 'Financial Express,' English and 'Jansatta', Hindi Newspaper, All India edition.

    Read More
    • 2020-07-29T14:37:45+00:00

    ADVIK LABORATORIES LTD. - 531686 - Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March, 2020 As Required U/R 33 Of The SEBI (LODR) Regulations, 2015.

    Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Wednesday, 29th July, 2020 at the corporate office of the company at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded just now has, inter-alia, transacted the following businesses: Considered and Approved the Standalone Audited Financial Results of the Company for the quarter and year ended 31st March, 2020 have considered and adopted the business mentioned in the outcome enclosed herewith.

    Read More
    • 2020-07-29T14:30:58+00:00

    ADVIK LABORATORIES LTD. - 531686 - Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March, 2020 As Required U/R 33 Of The SEBI (LODR) Regulations, 2015.

    Outcome of the Board Meeting and Submission of Audited Financial Results for the quarter and year ended 31st March, 2020 as required u/r 33 of the SEBI (LODR) Regulations, 2015.

    Read More
    • 2020-07-24T07:03:31+00:00

    ADVIK LABORATORIES LTD. - 531686 - Compliances-Reg.24(A)-Annual Secretarial Compliance

    Pursuant to Regulation 24A of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 08, 2019, please find enclosed herewith 'Annual Secretarial Compliance Report' for the year ended 31st March, 2020 duly signed by Kundan Agrawal & Associates, Practicing Company Secretary for your kind perusal.

    Read More
    • 2020-07-22T07:26:03+00:00

    ADVIK LABORATORIES LTD. - 531686 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 33 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find enclosed herewith a copy of newspaper publication w.r.t Notice of Board Meeting for considering the Audited Financial Results for the quarter and year ended 31st March, 2020, published on 22nd July, 2020 in 'Financial Express', English and 'Jansatta', Hindi Newspaper, All India Edition.

    Read More
    • 2020-07-21T12:24:43+00:00

    ADVIK LABORATORIES LTD. - 531686 - Board Meeting Intimation for Notice Of Board Meeting To Consider Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2020.

    ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations, 2015, notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Wednesday, 29th July, 2020 at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001 to inter-alia, consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2020 and to carry on any other business with the permission of the Board.

    Read More
    • 2020-07-16T11:37:21+00:00

    ADVIK LABORATORIES LTD. - 531686 - Shareholding for the Period Ended June 30, 2020

    Advik Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here

    Read More
    • 2020-07-13T09:32:37+00:00

    ADVIK LABORATORIES LTD. - 531686 - Statement Of Investor Complaints For The Quarter Ended June 2020

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- POOJA CHUNIDesignation :- Company Secretary and Compliance Officer

    Read More
    • 2020-07-06T11:17:38+00:00

    ADVIK LABORATORIES LTD. - 531686 - Disclosure Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions For The Quarter Ended 30Th June, 2020

    Please find enclosed herewith Disclosure of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions in the prescribed format for the quarter ended 30th June, 2020 pursuant to the SEBI circular no.SEBI/HO/CFD/CMDI/CIR/P/2019/140 dated 21st November, 2019 for your kind perusal.

    Read More
    • 2020-07-06T11:11:37+00:00

    ADVIK LABORATORIES LTD. - 531686 - Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities

    Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities

    Read More
    • 2020-07-01T07:08:22+00:00

    ADVIK LABORATORIES LTD. - 531686 - Closure of Trading Window

    Intimation of Continuation of Closure of Trading Window

    Read More
    • 2020-06-25T08:59:05+00:00

    ADVIK LABORATORIES LTD. - 531686 - Cancellation of Board Meeting

    The Board Meeting to be held on 30/06/2020 Stands Cancelled.

    Read More

Advik Laboratories Ltd. has not announced any dividend since Jan 1, 2000.

Ex-date Dividend Amount Dividend Type Record Date

Bonus History

Adani Ports & Special Economic Zone Ltd. has not announced any bonus since Jan 1, 2000.

Check out stocks with top dividend

Adani Ports & Special Economic Zone Ltd. has split the face value 1 time since Sept. 23, 2010. Adani Ports & Special Economic Zone Ltd. had last split the face value of its shares from Rs 10 to Rs 2 in 2016.The share has been quoting on an ex-split basis from Sept. 23, 2010.

Ex-date Old FV New FV Record Date
Sept. 23, 2010 10 FINAL Sept. 24, 2010